“An analysis by the publication Science has ‘found widespread after-the-fact payments or research support’ from pharmaceutical companies to expert officials who advised the Food and Drug Administration to approve those companies’ drugs.”
— “Pharma companies pay FDA advisers after drugs are approved,” Bob Herman, Axios
More:
“Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns,” Charles Piller and Jia You, Science
“Majority of doctors who oversee FDA drug approval receive payments from companies they monitor, report shows,” Clark Mindock, The Independent
____________
Short link: https://wp.me/p6sb6-rUa
Top image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht, NotionsCapital.com
Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.
Tags: Big Pharma, conflict of interest, ethics, FDA, FDA advisory committees, FDA drug review, Food and Drug Administration, pay-later conflicts of interest, pharmaceutical industry, pharmaceuticals, prescription drugs, Rx drugs
NotionsCapital 
Leave a Reply